Immunosuppressive Agents: all 5,940 studies that test it
Page 45 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- Everolimus in Treating Patients With Locally Advanced or Metastatic Thyroid CancerCompletedNCT01164176Phase 2
- Bortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant For High-Risk Stage I or II Multiple MyelomaCompletedNCT01163357Phase 1
- Cladribine Based Induction Therapy With All-Trans Retinoic Acid and Midostaurin in Relapsed/Refractory AMLCompletedNCT01161550Phase 1
- Efficacy and Safety of Belimumab in Subjects With Primary Sjögren's SyndromeCompletedNCT01160666Phase 2
- Drug Interaction Between Colchicine and Calcineurin Inhibitors in Renal Graft RecipientsCompletedNCT01160276Phase 1
- A Study to Compare the Effectiveness of a Drug That Suppresses the Immune System Called Thymoglobulin® in Preventing the Development of a Disease That Affects the Majority of Heart Transplant Recipients Called Cardiac Allograft Vasculopathy (CAV)WithdrawnNCT01157949Phase 3
- Everolimus and LongActing Octreotide Trial in Polycystic LiversCompletedNCT01157858Phase 2
- Everolimus MICE-regimen in Treating Older Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT01154439Phase 1
- Study of RAD001 in Adenoid Cystic CarcinomaCompletedNCT01152840Phase 2
- RAD001 in Pheochromocytoma or Nonfunctioning CarcinoidCompletedNCT01152827Phase 2
- Safety of RAD001 in Chinese Patients With Metastatic Renal Cell CancerCompletedNCT01152801Phase 1
- Attenuating Ischemia Reperfusion Injury After Living Donor Renal TransplantationWithdrawnNCT01149993Phase 4
- Study of Chemo-Immunotherapy in Head and Neck Cancer PatientsStatus unknownNCT01149902Phase 1
- High-dose Chemotherapy and Stem Cell Transplantation for Central Nervous System (CNS) Relapse of Aggressive LymphomasStatus unknownNCT01148173Phase 2
- Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25 mg With Those of Enbrel®CompletedNCT01145950Phase 1
- Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural MesotheliomasTerminatedNCT01143545Phase 1
- A Study of Belimumab in Treating Symptomatic Waldenstroms MacroglobulinaemiaStatus unknownNCT01142011Phase 2
- Evaluating the Combination of Everolimus and Sorafenib in the Treatment of Thyroid CancerActive, not recruitingNCT01141309Phase 2
- Adoptive Transfer of Autologous T Cells Targeted to Prostate Specific Membrane Antigen (PSMA) for the Treatment of Castrate Metastatic Prostate Cancer (CMPC)Active, not recruitingNCT01140373Phase 1
- Safety Study of Darinaparsin in Combination With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) to Treat LymphomaWithdrawnNCT01139359Phase 1
- Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal CancerCompletedNCT01139138Phase 1/2
- Study of Vinblastine and Sirolimus in Children With Recurrent/Refractory Solid Tumours Including CNS TumoursCompletedNCT01135563Phase 1
- An Open-label Study to Evaluate the Efficacy of Re-treatment for Patients With a History of Etanercept UseStatus unknownNCT01132235Phase 4
- Bioavailability Study of Tacrolimus Capsules, 5 mg of Dr. Reddys's Laboratories Limited Under Non-Fasting ConditionsCompletedNCT01132027Phase 1
- Bioavailability Study of Tacrolimus Capsules, 5 mg of Dr. Reddy's Under Fasting ConditionsCompletedNCT01131988Phase 1
- Metronomic Therapy in Metastatic Breast Cancer.CompletedNCT01131195Phase 3
- Reduced-Intensity Preparative Regimen for Allogeneic Stem Cell Transplantation in Patients With Severe Aplastic AnemiaWithdrawnNCT01129323Not applicable
- Tolerability and Safety and Health Outcomes in Relapsing Multiple Sclerosis (MS) PatientsCompletedNCT01127750Phase 3
- Study of RAD001 + AMG479 for Patients With Advanced Solid TumorsCompletedNCT01122199Phase 1
- Success of Tocilizumab in RA Patients With Remission Induction and Sustained Efficacy After DiscontinuationCompletedNCT01120366Phase 4
- Myocet Plus Endoxan for Older Patients With Breast CancerTerminatedNCT01120171Phase 2
- Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid CancerStatus unknownNCT01118065Phase 2
- Early Response-adapted Intensification of Induction Chemotherapy in Patients With Newly Diagnosed Multiple Myeloma (MM)Status unknownNCT01114048Phase 2
- Enteric-coated Mycophenolate Sodium Versus Azathioprine for the Extra-renal Lupus ManifestationsCompletedNCT01112215Phase 4
- Safety and Efficacy in LPL-Deficient Subjects of AMT-011, an Adeno-Associated Viral Vector Expressing Human Lipoprotein Lipase [S447X]Status unknownNCT01109498Phase 2/3
- Pilot Study of Neo-Adjuvant Everolimus to Treat Advanced Renal Cell Carcinoma - Analysis of BiomarkersCompletedNCT01107509Not applicable
- Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Metastatic MelanomaTerminatedNCT01106235Phase 1
- Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Aplastic AnemiaCompletedNCT01105273Phase 1/2
- A Trial of RAD001/Capecitabine in Refractory Gastric CancerCompletedNCT01099527Phase 1/2
- A Study to Explore Efficacy and Safety of ASP015K in Subjects With Moderate to Severe PsoriasisCompletedNCT01096862Phase 2
- A Study of TS-1, Cisplatin (CDDP) and RAD001 (Everolimus)TerminatedNCT01096199Phase 1
- Efficacy, Safety and Tolerability of Repeated Dosis of Intravitreous Bevacizumab in Uveitic Macular OedemaTerminatedNCT01095809Phase 3
- Thalidomide for Patients With Mild to Moderate Alzheimer's DiseaseStatus unknownNCT01094340Phase 2/3
- Lenalidomide and Dexamethasone Versus Melphalan Prednisone and Lenalidomide Versus Cyclophosphamide, Prednisone and Lenalidomide in Elderly Multiple Myeloma PatientsCompletedNCT01093196Phase 3
- Insulin Secretion and AdvagrafCompletedNCT01092806Phase 4
- Cyclophosphamide, Lenalidomide and Dexamethasone (CRD) Versus Melphalan (200 mg/m2) Followed By Autologous Stem Cell Transplant (ASCT) In Newly Diagnosed Multiple Myeloma SubjectsCompletedNCT01091831Phase 3
- Evaluation of the Effects of Certolizumab Pegol on Semen Quality in Healthy Male VolunteersCompletedNCT01091220Phase 1
- Study of Cimzia for the Treatment of Ulcerative ColitisCompletedNCT01090154Phase 2
- Study of Neoadjuvant Chemotherapy With Nanoparticle Albumin Bound Paclitaxel, Doxorubicin and Cyclophosphamide (NAC) in Patients With Stages II-III Breast CancerTerminatedNCT01090128Phase 1
- Everolimus in Breast Cancer Patients After Pre-operative ChemotherapyStatus unknownNCT01088893Phase 2
- Surgery Alone or With CYC VBL and PRED or CVP Alone in Stage IA or IIA Nodular Lymphocyte-Predominant Hodgkin LymphomaCompletedNCT01088750Phase 4
- Fludarabine, Cyclophosphamide, Doxorubicin and Rituximab for the Treatment of Post-transplant Lymphoproliferative Disease (PTLD)CompletedNCT01088724Phase 4
- Lapatinib With Sirolimus or MetforminCompletedNCT01087983Phase 1
- Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced CancerActive, not recruitingNCT01087554Phase 1
- Hematopoietic Stem Cell Transplantation for Malignant Infantile OsteopetrosisStatus unknownNCT01087398Phase 2/3
- Standard Chemotherapy with or Without Nelarabine or Rituximab in Treating Patients with Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT01085617
- Therapeutic Effect of Tacrolimus in Combination With Low Dose Corticosteroid in Adult Patient With Minimal Change Nephritic SyndromeCompletedNCT01084980Phase 2/3
- Bioequivalence Study of Tacrolimus 5 mg Capsule Under Fed ConditionCompletedNCT01080534Not applicable
- Bioequivalence Study of Tacrolimus 5 mg Capsule Under Fasting ConditionCompletedNCT01080482Not applicable
- Bioequivalence Study of Tacrolimus 1 mg Capsule Under Fed ConditionCompletedNCT01080469Not applicable
- Bioequivalence Study of Tacrolimus 1 mg Capsule Under Fasting ConditionCompletedNCT01080456Not applicable
- Everolimus and Capecitabine in Patients With Advanced MalignancyStatus unknownNCT01079702Phase 1/2
- Combination Anticancer Therapy of Paclitaxel and Everolimus for Relapsed or Refractory Small Cell Lung CancerCompletedNCT01079481Phase 1
- Everolimus, Cetuximab and Capecitabine in Patients With Metastatic Pancreatic CancerCompletedNCT01077986Phase 1/2
- Cyclophosphamide, Alvocidib, and Rituximab in Treating Patients With High Risk B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaTerminatedNCT01076556Phase 1
- Phase I Study in RAD 001 Patients With Relapse AMLCompletedNCT01074086Phase 1
- Plerixafor and Filgrastim Following Cyclophosphamide for Stem Cell Mobilization in Patients With Multiple MyelomaCompletedNCT01074060Phase 1
- The Effectiveness of Selective Nerve Root Injections in Preventing the Need for SurgeryCompletedNCT01073995Phase 3
- Hematopoietic Stem Cell Transplant for Fanconi AnemiaCompletedNCT01071239Phase 2
- Multiple Myeloma Treated With Thalidomide Before Autotransplant or With Conventional Chemotherapy and as Consolidation/Maintenance Treatment in Young and Elderly Patients : 3 Randomized Studies.CompletedNCT01070862Phase 3
- Pharmacokinetics Profile Study of BG00012 Standard Formulation and BG00012 Active Pharmaceutical IngredientCompletedNCT01069913Phase 1
- Erosive Osteoarthritis of the Hands: Treatment by Methotrexate Versus PlaceboCompletedNCT01068405Phase 3
- Safety and Tolerability of Etanercept in Alzheimer's DiseaseCompletedNCT01068353Phase 2
- Efficacy Study of FK-506 and Cyclosporine in Vernal Keratoconjunctivits (VKC)CompletedNCT01068054Phase 2/3
- Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast CancerTerminatedNCT01067989Phase 2
- Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLCTerminatedNCT01063478Phase 1
- Velcade, Melphalan, Prednisone And Thalidomide Versus Velcade, Melphalan, Prednisone in Multiple Myeloma PatientsCompletedNCT01063179Phase 3
- Basiliximab Maintenance in Ulcerative ColitisTerminatedNCT01061996Phase 2
- A Trial of AMG 479, Everolimus (RAD001) and Panitumumab in Patients With Advanced Cancer - QUILT-3.007CompletedNCT01061788Phase 1
- Pre Transplant Rapamycin Treatment in Islet Transplantation AloneCompletedNCT01060605Phase 3
- Safety and Tolerability of LIM-0705 in Healthy Male SubjectsCompletedNCT01060475Phase 1
- RAD001 With Weekly Cisplatin and Radiation Therapy in Patients With Locally Advanced Head and Neck CancerTerminatedNCT01058408Phase 1
- Neo Adjuvant Chemotherapy in Triple Negative Breast CancerActive, not recruitingNCT01057069Phase 2/3
- Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid MalignanciesCompletedNCT01056614Phase 2
- Long-Term Study of Multi-target Therapy as Maintenance Treatment for Lupus NephritisCompletedNCT01056237Not applicable
- a Comparative Pharmacokinetic Study of Two Oral Formulations of Tacrolimus in Renal Allograft RecipientsCompletedNCT01055964Phase 3
- Safety Study of Bevacizumab, Everolimus and LBH589 (BEL) for Advanced Solid TumorsCompletedNCT01055795Phase 1
- S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple MyelomaWithdrawnNCT01055301Phase 2
- Docetaxel and Sirolimus in Patients With Advanced MalignanciesCompletedNCT01054313Phase 1
- Assessment of Small Bowel Healing in Crohn's Disease Patients Treated With Cimzia Using Wireless Capsule EndoscopyCompletedNCT01053559Not applicable
- Efficacy and Safety of Deoxyspergualin in Renal Transplant Patient With Chronic RejectionTerminatedNCT01052259Not applicable
- CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor TransplantCompletedNCT01049854Phase 2
- RAD001 in Combination With Capecitabine and Oxaliplatin (XELOX) in Patients With Advanced Gastric Cancer: RAD001+XELOXCompletedNCT01049620Phase 1
- Anthracycline-free Taxane Based Chemotherapy in Patients With HER2/Neu Negative Early Breast CancerCompletedNCT01049425Phase 3
- Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine FeaturesCompletedNCT01048892Phase 1
- Low-Dose Conditioning Followed by Donor Stem Cell Transplant in Treating Patients With Severe Systemic SclerosisWithdrawnNCT01047072Phase 2
- Thymoglobulin Versus Alemtuzumab Versus Daclizumab in Living Donor Renal TransplantationCompletedNCT01046955Phase 4
- Everolimus Rescue Immunosuppression in the Treatment of Chronic Allograft Dysfunction in Renal Transplant RecipientsCompletedNCT01046045Phase 4
- Safety and Pharmacokinetic Characteristics of HD203 in Healthy Male VolunteersCompletedNCT01044836Phase 1
- Intravitreal Bevasizumab Versus Intravitreal Triamcinolone in Branch Retinal Vein OcclusionStatus unknownNCT01044329Phase 2